CIC
CVS icon

Crawford Investment Counsel’s CVS Health CVS Stock Holding History

Crawford Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,106
Closed -$324K – 274
2023
Q4 		$324K Sell
4,106
-172
-4% -$12.2K 0.01% 240
2023
Q3 		$299K Sell
4,278
-1,252
-23% -$88.7K 0.01% 248
2023
Q2 		$382K Sell
5,530
-70
-1% -$4.98K 0.01% 241
2023
Q1 		$416K Sell
5,600
-763
-12% -$64K 0.01% 231
2022
Q4 		$593K Buy
6,363
+494
+8% +$47.7K 0.01% 218
2022
Q3 		$560K Sell
5,869
-45
-0.8% -$4.45K 0.01% 218
2022
Q2 		$548K Buy
5,914
+768
+15% +$75K 0.01% 226
2022
Q1 		$521K Sell
5,146
-20
-0.4% -$2.1K 0.01% 236
2021
Q4 		$533K Sell
5,166
-704
-12% -$65.1K 0.01% 235
2021
Q3 		$498K Buy
5,870
+525
+10% +$44K 0.01% 239
2021
Q2 		$446K Sell
5,345
-238
-4% -$19.5K 0.01% 242
2021
Q1 		$420K Sell
5,583
-1,556
-22% -$113K 0.01% 228
2020
Q4 		$488K Buy
7,139
+872
+14% +$56.7K 0.01% 213
2020
Q3 		$366K Sell
6,267
-208
-3% -$12.9K 0.01% 224
2020
Q2 		$421K Buy
6,475
+1,965
+44% +$124K 0.01% 217
2020
Q1 		$268K Sell
4,510
-76
-2% -$5.07K 0.01% 234
2019
Q4 		$341K Buy
4,586
+658
+17% +$46.2K 0.01% 236
2019
Q3 		$248K Buy
+3,928
New +$233K 0.01% 254
2019
Q1 		– Sell
-4,997
Closed -$327K – 254
2018
Q4 		$327K Buy
+4,997
New +$373K 0.01% 221
2018
Q3 		– Sell
-10,077
Closed -$648K – 260
2018
Q2 		$648K Sell
10,077
-40,086
-80% -$2.64M 0.02% 185
2018
Q1 		$3.12M Sell
50,163
-619,476
-93% -$44.4M 0.1% 108
2017
Q4 		$48.5M Sell
669,639
-72,366
-10% -$5.26M 1.51% 28
2017
Q3 		$60.3M Buy
742,005
+54,773
+8% +$4.33M 1.96% 18
2017
Q2 		$55.3M Buy
687,232
+43,615
+7% +$3.44M 1.9% 19
2017
Q1 		$50.5M Buy
643,617
+570,535
+781% +$45.5M 1.79% 23
2016
Q4 		$5.77M Buy
+73,082
New +$5.91M 0.21% 76

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crawford Investment Counsel's CVS Position: Q1 2024 in Review

Crawford Investment Counsel sold out of CVS Health (CVS) in Q1 2024, closing a stake of 4,106 shares — an estimated $324K sold.

Crawford Investment Counsel first reported a position in CVS in Q4 2016 and held it in 26 quarters. The position peaked at $60.3M in Q3 2017. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Crawford Investment Counsel reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Crawford Investment Counsel sold 4,106 CVS Health shares in Q1 2024, an estimated $324K.
  • Crawford Investment Counsel first reported a position in CVS Health in Q4 2016 and held it in 26 quarters.
  • Crawford Investment Counsel's CVS Health position peaked at $60.3M in Q3 2017.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Crawford Investment Counsel's 13F filing for Q1 2024, filed 15 May 2024.